- A magnificent share rally in Tandem Diabetes Care has ensued this year as it became clear to investors that the company isn’t going belly-up.
- Quite the contrary, revenues are increasing at a very brisk pace (44%) and the prospects for this to continue are pretty good.
- However, the company still makes very substantial losses, and these aren’t disappearing overnight whilst the shares already sell for over 10x sales.
- So we think the shares are in need of cooling off a bit.
Epic Rally In Tandem Diabetes Care, Can It Continue?
June 30th, 2018 · No Comments